Logotipo ImpactU
Autor

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Acceso Abierto

Abstract:

Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 and has rapidly spread throughout the world leading to an international pandemic.1 Although most cases of COVID-19 are mild, the disease can become severe and result in hospitalization, respiratory failure, or death with reported case fatality rates ranging from 2.3% to 7.2%.2,3 To date, the most frequently identified risk factors for severe COVID-19 have been age, cardiovascular disease, chronic lung conditions, obesity, and diabetes.2,4 In a recent report from the United States, 78% of patients requiring intensive care unit (ICU) admission had at least 1 underlying comorbidity

Tópico:

Inflammatory Bowel Disease

Citaciones:

Citations: 668
668

Citaciones por año:

Altmétricas:

Paperbuzz Score: 0
0

Información de la Fuente:

SCImago Journal & Country Rank
FuenteGastroenterology
Cuartil año de publicaciónNo disponible
Volumen159
Issue2
Páginas481 - 491.e3
pISSNNo disponible
ISSN0016-5085

Enlaces e Identificadores:

Artículo de revista